Your browser doesn't support javascript.
loading
Maintenance azacitidine after myeloablative allogeneic hematopoietic cell transplantation for myeloid malignancies.
Maples, Kathryn T; Sabo, Roy T; McCarty, John M; Toor, Amir A; Hawks, Kelly G.
Afiliação
  • Maples KT; a Department of Pharmacy Services, VCU School of Pharmacy , Virginia Commonwealth University Health , Richmond , VA , USA.
  • Sabo RT; b Department of Biostatistics , Virginia Commonwealth University , Richmond , VA , USA.
  • McCarty JM; c Bone Marrow Transplant Program, Massey Cancer Center, Department of Internal Medicine , Virginia Commonwealth University Health , Richmond , VA , USA.
  • Toor AA; c Bone Marrow Transplant Program, Massey Cancer Center, Department of Internal Medicine , Virginia Commonwealth University Health , Richmond , VA , USA.
  • Hawks KG; a Department of Pharmacy Services, VCU School of Pharmacy , Virginia Commonwealth University Health , Richmond , VA , USA.
Leuk Lymphoma ; 59(12): 2836-2841, 2018 12.
Article em En | MEDLINE | ID: mdl-29616863

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Azacitidina / Síndromes Mielodisplásicas / Leucemia Mieloide Aguda / Transplante de Células-Tronco Hematopoéticas / Recidiva Local de Neoplasia / Antimetabólitos Antineoplásicos Tipo de estudo: Evaluation_studies / Observational_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Azacitidina / Síndromes Mielodisplásicas / Leucemia Mieloide Aguda / Transplante de Células-Tronco Hematopoéticas / Recidiva Local de Neoplasia / Antimetabólitos Antineoplásicos Tipo de estudo: Evaluation_studies / Observational_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article